IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
IM Cannabis Corp.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 30, 2026
$1.50+0.11 (+7.91%)
Close on Oct 19, 2026
Share price
−$59.11 (−97.53%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
IM Cannabis Corp. grew revenue 1.3% to C$54.73M over fiscal 2025. Free cash flow was C$4.70M.
Revenue
C$54.73M
+1.3% vs. a year earlier
Operating income
-C$11.59M
FY2025
Free cash flow
C$4.70M
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- C$54.73M
- Net income
- -C$11.32M
- Free cash flow
- C$4.70M
Valuation needs the share price. It fills in once daily prices are connected and converted from CAD.
Eight years at a glance
Fiscal years 2018 to 2025, CAD
Revenue
C$54.73M+1.3% YoY
Gross profit
C$9.69M+14.6% YoY
Operating income
-C$11.59M
Net income
-C$11.32M
EPS, diluted
–
Free cash flow
C$4.70M
Reported period